| scholarly article | Q13442814 |
| P2093 | author name string | William B. Campbell | |
| Anne M. Estes | |||
| Eduard N. Lavrentyev | |||
| Kafait U. Malik | |||
| Chi Young Song | |||
| Fariborz A. Yaghini | |||
| Hafiz U. B. Ghafoor | |||
| Xiao R. Fang | |||
| P2860 | cites work | Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1 | Q24299549 |
| Chemistry and antihypertensive effects of tempol and other nitroxides | Q24658069 | ||
| Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells | Q28572220 | ||
| CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression | Q28592244 | ||
| P-450 metabolites of arachidonic acid in the control of cardiovascular function | Q29620578 | ||
| Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation | Q33574889 | ||
| Reactive oxygen species as mediators of angiotensin II signaling | Q34019811 | ||
| Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. | Q34106420 | ||
| Angiotensin II and atherosclerosis | Q34239830 | ||
| Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. | Q34289529 | ||
| The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. | Q34552443 | ||
| The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. | Q34690091 | ||
| Inflammation and angiotensin II. | Q35099157 | ||
| Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. | Q35605118 | ||
| Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? | Q35840821 | ||
| NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease | Q36110357 | ||
| Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension. | Q36863470 | ||
| Arachidonic Acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling | Q37037140 | ||
| Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress | Q37096986 | ||
| Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells | Q37168707 | ||
| CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration | Q37299808 | ||
| 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. | Q37363103 | ||
| Reactive oxygen species from the uncoupling of human cytochrome P450 1B1 may contribute to the carcinogenicity of dioxin-like polychlorinated biphenyls. | Q39967818 | ||
| 20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells | Q40169321 | ||
| Renal cytochrome P450. | Q41088101 | ||
| Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation | Q41662259 | ||
| Arthur C. Corcoran Memorial Lecture. The role of eicosanoids in angiotensin-dependent hypertension | Q41695612 | ||
| The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angioten | Q42515569 | ||
| Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. | Q43640230 | ||
| A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. | Q43806549 | ||
| Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade | Q43907232 | ||
| Reduced Growth Factor Responses in Vascular Smooth Muscle Cells Derived from 12/15-Lipoxygenase–Deficient Mice | Q44411450 | ||
| Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation | Q44413513 | ||
| Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II-induced neointimal growth | Q46493558 | ||
| Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy | Q47563669 | ||
| Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. | Q50138582 | ||
| Arachidonic Acid Metabolites Mediate Angiotensin II-Induced NADH/NADPH Oxidase Activity and Hypertrophy in Vascular Smooth Muscle Cells | Q63365779 | ||
| Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophages | Q71536778 | ||
| Comparative effect of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration | Q71633119 | ||
| Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites | Q73098416 | ||
| Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species | Q73675626 | ||
| Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells | Q74064560 | ||
| Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling | Q74132582 | ||
| Constitutive and inducible expression of cytochrome P450IA1 and P450IB1 in human vascular endothelial and smooth muscle cells | Q77483220 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell migration | Q189092 |
| P304 | page(s) | 1461–1467 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation | |
| P478 | volume | 55 |
| Q34426173 | 2,3′,4,5′-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1 |
| Q92708053 | 6β-Hydroxytestosterone, a metabolite of testosterone generated by CYP1B1, contributes to vascular changes in angiotensin II-induced hypertension in male mice |
| Q35821431 | AVE0991, a Nonpeptide Compound, Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation via Induction of Heme Oxygenase-1 and Downregulation of p-38 MAPK Phosphorylation |
| Q36198189 | Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway |
| Q37832995 | Cell signaling of angiotensin II on vascular tone: novel mechanisms |
| Q35919773 | Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents |
| Q41817139 | Cytochrome P450 1B1 Contributes to the Development of Angiotensin II-Induced Aortic Aneurysm in Male Apoe(-/-) Mice |
| Q36354759 | Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice |
| Q58126981 | Cytochrome P450 1B1 Is Critical for Neointimal Growth in Wire-Injured Carotid Artery of Male Mice |
| Q34157216 | Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology |
| Q35105331 | Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats |
| Q35707118 | Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice |
| Q36403672 | Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice |
| Q33889096 | Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation. |
| Q36573633 | Cytosolic Phospholipase A2α Is Essential for Renal Dysfunction and End-Organ Damage Associated With Angiotensin II-Induced Hypertension |
| Q35175554 | Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology |
| Q37962590 | Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors |
| Q64085201 | Endothelial progenitor cells, rosuvastatin and valsartan have a comparable effect on repair of balloon-denudated carotid artery injury |
| Q41265501 | Glycation of high-density lipoprotein triggers oxidative stress and promotes the proliferation and migration of vascular smooth muscle cells |
| Q58554361 | Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation |
| Q51292454 | Identification of CYP1B1-specific candidate inhibitors using combination of in silico screening, integrated knowledge-based filtering, and molecular dynamics simulations. |
| Q90093153 | Immune Cells in the Uterine Remodeling: Are They the Target of Endocrine Disrupting Chemicals? |
| Q35787438 | Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats |
| Q35683744 | Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling |
| Q35974597 | Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells |
| Q37580782 | Microvesicles Derived from Inflammation-Challenged Endothelial Cells Modulate Vascular Smooth Muscle Cell Functions |
| Q112720068 | Off-target effects of oral anticoagulants - vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate |
| Q36185160 | PGC-1α limits angiotensin II-induced rat vascular smooth muscle cells proliferation via attenuating NOX1-mediated generation of reactive oxygen species |
| Q39189895 | Potential role of CYP1B1 in the development and treatment of metabolic diseases |
| Q39552993 | Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells |
| Q35135052 | Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration |
| Q38170474 | Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. |
| Q47141307 | The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation. |
| Q38224257 | The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis |
| Q55394065 | The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series). |
| Q42774938 | Transcriptome profiling reveals that the SM22α-regulated molecular pathways contribute to vascular pathology |
| Q30430202 | Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function |
| Q42704155 | Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway. |
| Q37832151 | Vascular smooth muscle cell motility: From migration to invasion |
Search more.